Skip to main content
Fig. 2 | Trials

Fig. 2

From: Effects of the Chinese herbal formula San-Huang Gu-Ben Zhi-Ke treatment on stable chronic obstructive pulmonary disease: study protocol of a randomized, double-blind, placebo-controlled trial

Fig. 2

Schedule of enrollment, intervention, and assessments. Adverse events, physical examination, AECOPD situation and MMRC, CAT, and TCM symptom scores (TCM symptoms of patients with stable COPD diagnosed with deficiency of lung qi and spleen qi) will be recorded at baseline (week 0) and every 4 weeks during the study period. The 6-min walking distance and BODE will be recorded at weeks 0, 4, 12, 24, 32, and 52. Lung function will be determined at weeks 0, 24, and 52. Safety will be measured at weeks 0, 12, and 24, except for adverse events and physical examination

Back to article page

Trials

ISSN: 1745-6215